尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Chinoporos Constantine. Officer active across 1 company, notably Applied Therapeutics, Inc.. Aggregated, 5 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €17k. Activity tracked since 28 December 2023. The latest transaction was disclosed on 19 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Chinoporos Constantine is a declarant linked to Applied Therapeutics, Inc. (XNAS), with the role noted as "See Remarks". Across 5 filings, the sampled recent filings from 2024-03-18 to 2026-02-03 show sales of EUR 16678 and no buys, and the modal transaction nature is "Attribution".